Did you know that musculoskeletal injuries (MSK) are among the most common injuries sustained in the workplace?
The Bureau of Labor Statistics says that about 272,780 cases of musculoskeletal disorders were reported in the U.S. in 2018. That's a lot of people who are dealing with pain and suffering daily! Though musculoskeletal injuries can be a source of pain and discomfort for employees, they can also be costly to employers. The Institute of Medicine has estimated that work-related musculoskeletal disorders (MSDs) cost between $45 and $54 billion per year. This includes the costs of compensation, lost wages, and lost productivity.
By following a few simple precautions, employees can prevent MSK issues. This article will discuss the causes of workplace injuries, prevention tips, and employee health. We will also explore how employers can plan and support employees to prevent workplace injuries.
Why MSK Injuries Occur in Employees
Musculoskeletal injuries in employees occur for a variety of reasons. However, some typical causes are as follows:• Using equipment that isn't ergonomically designed.
• Lifting or carrying heavy weights or loads
• Ongoing exposure to whole-body vibration
• Recurring overhead work
• Working with the neck bent forward for long periods
• Doing tasks that require a lot of force over and over again
Employees doing the same tasks repeatedly can be hard on their bodies. They are not able to fully relax and recover between functions. Over time, it becomes more challenging to execute the same monotonous activities. Plus, when people are tired, they are more likely to be hurt on the job.
Industry-Specific MSK Injuries
MSK injuries can vary depending on the industry and job type. For instance, the incidence of MSK injuries in farming is significant. The CDC claims that 58% of all musculoskeletal problems occur in the following jobs:• Operators
• Fabricators
• Laborers
• Technical
• Sales
• Administrative support jobs
The Cost of MSK Injuries
Musculoskeletal disorders are a significant cause of work-related illness and a substantial financial, economic, and social burden for individuals and society.
Medical MSK Care Cost
Musculoskeletal issues are costly for businesses. This includes the cost of absenteeism, missed production, and increased health care costs. Costs directly associated with MSD amount to $20 billion each year. The total yearly cost is between $45 and $54 billion.
Indirect Cost to Employers Indirect costs include that related to:
• Lost productivity
• Temporary disability
• Permanent disability
• Early retirement due to injury or illness
• Worker's comp
• Unemployment from time off because of an injury
The indirect costs of MSK injuries to employers are as high as five times the direct costs.
How Employers Can Help Prevent Workplace MSK Injuries
Employers have a responsibility to prevent work-related musculoskeletal disorders. They can accomplish this by equipping workers with the tools they require to be healthy and safe on the job. Here are some suggestions for avoiding MSK injuries.
1. Provide employers with ergonomic training and musculoskeletal care wellness programs to educate staff on how to adjust their workstations and equipment.
2. Encourage employees to take breaks often, stretch, and move around regularly.
3. Ensure employees have the appropriate tools and equipment to do their job safely and comfortably.
4. Conduct regular safety training and assessments of the work environment.
5. Physical therapists can help prevent and treat MSK injuries through employee health and wellness programs implemented at the organization level.
One such employee health and wellness program is available at TheraNow. TheraNow is a pioneer in telehealth regarding preventive health, wellness, and rehabilitation. In addition, TheraNow is a digital musculoskeletal (MSK) care ecosystem, the most advanced technology and network for occupational health and physical therapy. As a result, TheraNow is the only all-in-one solution for prevention, wellness and early intervention, and medical management of musculoskeletal (MSK) injuries.
TheraNow's artificial intelligence-powered preventive health program with computer vision tech is designed for employers and health plans. Each employee or member is given access to unlimited digital MSK, and ergonomic risk assessment and custom exercise plans, educational content, and recommendations are provided by board-certified physical therapists after a thorough assessment of their risk profiles. In addition, personalized 1-on-1 virtual sessions are also offered with experts for employees or members with moderate to high-risk profiles.
The employers can choose from TheraNow's competitive plans according to their requirements and save millions of dollars in direct and indirect musculoskeletal (MSK) care costs after injuries. Request a Demo Today to learn more about TheraNow's MSK program.
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Musculoskeletal Disorders Drugs Global Market Report 2020-30 by The Business Research Company describes and explains the global musculoskeletal disorders drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Musculoskeletal Disorders Drugs Global Market Report 2021 covers musculoskeletal disorders drugs market drivers, musculoskeletal disorders drugs market trends, musculoskeletal disorders drugs market segments, musculoskeletal disorders drugs market growth rate, musculoskeletal disorders drugs market major players, and musculoskeletal disorders drugs market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2020-30-covid-19-impact-and-recoveryThe musculoskeletal disorders drugs market report provides an in-depth analysis of the impact of COVID-19 on the global musculoskeletal disorders drugs industry, along with revised market numbers due to the effects of the coronavirus and the expected musculoskeletal disorders drugs market growth numbers 2021-2030.Musculoskeletal Disorders Drugs Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2140=smpThe global musculoskeletal disorders drugs market is expected to grow from $81.08 billion in 2020 to $85.6 billion in 2021 at a compound annual growth rate (CAGR) of 5.6%.
The market is expected to reach $100.76 billion in 2025 at a CAGR of 4%.The report covers the musculoskeletal disorders drugs market’s segments-1) By Type: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs.2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.3) By Route Of Administration: Oral, Parenteral, Others.4) By Drug Classification: Branded Drugs, Generic Drugs.5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.
Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The Business Research Company published its Musculoskeletal Disorders Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market.
The report covers the musculoskeletal disorders drugs market’s segments- by type: drugs for rheumatoid arthritis; muscle relaxants; others - musculoskeletal disorders drugs, by distribution channel: hospital pharmacies; retail pharmacies/ drug stores; others, by route of administration: oral; parenteral; others, by drug classification: branded drugs; generic drugs, and by mode of purchase: prescription-based drugs; over-the-counter drugs.View Complete Report: https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorders-drugs-global-market-report-2020-30-covid-19-impact-and-recoveryMusculoskeletal Disorders Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
